Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan
- 31 March 2015
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 136 (4), 1018-1024
- https://doi.org/10.1016/j.jaci.2015.02.020
Abstract
No abstract availableFunding Information
- Ministry of Defense- Japan
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 19 references indexed in Scilit:
- CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndromeClinical Immunology, 2012
- Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligandBlood, 2011
- Successful unrelated cord blood transplantation for a patient with CD40 ligand deficiencyHaematologica, 2007
- Allogeneic hematopoietic stem cell transplantation for seven children with X‐linked hyper‐IgM syndrome: A single center experienceAmerican Journal of Hematology, 2004
- The X-Linked Hyper-IgM SyndromeMedicine, 2003
- Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002Blood, 2003
- Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndromeHuman Genetics, 1997
- CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndromeImmunology Today, 1996
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993